Neurizon Therapeutics (NUZ.AX) is trading 3.8 percent higher on Tuesday 27th of October and has a trading volume of AUD 26.7 k
Neurizon Therapeutics rises 3.8% on the ASX, trading at AUD 0.09 with a 64.9 M market cap. Explore its biotech focus on monepantel for neuro‑degenerative disease.
- NEURIZON THERAPEUTICS LTD
- Australia
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read